Keywords: csfb, starts, coverage, ligand, credit, suisse, first

CSFB starts coverage of Ligand

Article | 13 September 2001

Print This

Credit Suisse First Boston has started coverage of LigandPharmaceuticals with a buy rating and a 12-month share price target of $25. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in